Effect of plasma thrombin-antithrombin complex on ischemic stroke: a systematic review and meta-analysis

[1]  J. B. Salom,et al.  Clot Composition Analysis as a Diagnostic Tool to Gain Insight into Ischemic Stroke Etiology: A Systematic Review , 2021, Journal of stroke.

[2]  T. Meinel,et al.  Early Neurologic Deterioration in Lacunar Stroke , 2021, Neurology.

[3]  Simon Jung,et al.  Endovascular therapy in patients with large vessel occlusion due to cardioembolism versus large-artery atherosclerosis , 2021, Therapeutic advances in neurological disorders.

[4]  Surojit Paul,et al.  Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies , 2020, Experimental Neurology.

[5]  I. Santana,et al.  Pathophysiology of Blood–Brain Barrier Permeability Throughout the Different Stages of Ischemic Stroke and Its Implication on Hemorrhagic Transformation and Recovery , 2020, Frontiers in Neurology.

[6]  S. Misra,et al.  Blood biomarkers for the diagnosis and differentiation of stroke: A systematic review and meta-analysis , 2020, International journal of stroke : official journal of the International Stroke Society.

[7]  Wenman Wu,et al.  Evaluation of analytic and clinical performance of thrombin-antithrombin complex and D-dimer assay in prognosis of acute ischemic stroke. , 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[8]  M. Koga,et al.  D-dimer level and outcome of minor ischemic stroke with large vessel occlusion , 2020, Journal of the Neurological Sciences.

[9]  L. Badimón,et al.  Role of Autophagy in Von Willebrand Factor Secretion by Endothelial Cells and in the In Vivo Thrombin-Antithrombin Complex Formation Promoted by the HIV-1 Matrix Protein p17 , 2020, International journal of molecular sciences.

[10]  S. Doré,et al.  Biomarker Application for Precision Medicine in Stroke , 2019, Translational Stroke Research.

[11]  M. Dichgans,et al.  Stroke genetics: discovery, biology, and clinical applications , 2019, The Lancet Neurology.

[12]  H. Das,et al.  Current advances in ischemic stroke research and therapies. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[13]  J. Freedman,et al.  Thrombosis and platelets: an update. , 2016, European Heart Journal.

[14]  K. Abe,et al.  Thrombolysis with Low-Dose Tissue Plasminogen Activator 3–4.5 h After Acute Ischemic Stroke in Five Hospital Groups in Japan , 2016, Translational Stroke Research.

[15]  Li-Li Liu,et al.  Thrombomodulin and High-Sensitive C-Reactive Protein Levels in Blood Correlate with the Development of Cerebral Infarction Among Asians , 2016, Molecular Neurobiology.

[16]  E. V. van Dijk,et al.  The Prognostic Value of CT Angiography and CT Perfusion in Acute Ischemic Stroke , 2015, Cerebrovascular Diseases.

[17]  T. Nagai,et al.  Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism , 2015, Circulation.

[18]  T. Ohmori,et al.  Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study , 2014, Critical Care.

[19]  J. S. Lin,et al.  Analysis of thrombin‐antithrombin complex contents in plasma and hematoma fluid of hypertensive intracerebral hemorrhage patients after clot removal , 2011, European journal of neurology.

[20]  Xiaoying Wang,et al.  Antithrombin III associated with fibrinogen predicts the risk of cerebral ischemic stroke , 2011, Clinical Neurology and Neurosurgery.

[21]  A. Stang.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[22]  Xia Li,et al.  Meta-analysis of association between variation in the PDE4D gene and ischemic cerebral infarction risk in Asian populations , 2010, neurogenetics.

[23]  E. González-Toledo,et al.  Clinically presenting acute/subacute ischemic stroke: differential diagnosis of the non-enhanced CT hypodensity by advanced neuroimaging , 2009, Neurological research.

[24]  À. Rovira,et al.  Lower concentrations of thrombin-antithrombin complex (TAT) correlate to higher recanalisation rates among ischaemic stroke patients treated with t-PA , 2009, Thrombosis and Haemostasis.

[25]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[26]  J. Wardlaw,et al.  Factors Influencing the Detection of Early CT Signs of Cerebral Ischemia: An Internet-Based, International Multiobserver Study , 2007, Stroke.

[27]  Jeffrey L Saver,et al.  The Impact of Recanalization on Ischemic Stroke Outcome: A Meta-Analysis , 2007, Stroke.

[28]  D. Tanné,et al.  Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke , 2006, Stroke.

[29]  J. Choi,et al.  Plasma Level of IL-6 and Its Relationship to Procoagulant and Fibrinolytic Markers in Acute Ischemic Stroke , 2006, Yonsei medical journal.

[30]  I. Hozo,et al.  Estimating the mean and variance from the median, range, and the size of a sample , 2005, BMC medical research methodology.

[31]  M. Kaste,et al.  Serial changes in fibrinolysis and coagulation activation markers in acute and convalescent phase of ischemic stroke , 2004, Acta neurologica Scandinavica.

[32]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[33]  J. Aznar,et al.  Inflammation, fibrinogen and thrombin generation in patients with previous myocardial infarction. , 2002, Haematologica.

[34]  S. Kataoka,et al.  Activation of thrombosis and fibrinolysis following brain infarction , 2000, Journal of the Neurological Sciences.

[35]  J. Soler‐Soler,et al.  Thrombin formation and fibrinolytic activity in patients with acute myocardial infarction or unstable angina: in-hospital course and relationship with recurrent angina at rest. , 2000, Journal of the American College of Cardiology.

[36]  E. Fon,et al.  Hemostatic Markers in Acute Transient Ischemic Attacks , 1994, Stroke.

[37]  Y. Shinohara,et al.  Detection of prothrombotic state in ischemic stroke by monitoring plasma molecular markers. , 1994, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[38]  S. Uchiyama,et al.  Alterations of haemostatic markers in various subtypes and phases of stroke. , 1993, Blood Coagulation and Fibrinolysis.

[39]  K. Takano,et al.  Markers of a hypercoagulable state following acute ischemic stroke. , 1992, Stroke.

[40]  K. Oku,et al.  Clinical Significance of New Coagulation and Fibrinolytic Markers in Ischemic Stroke Patients , 1991, Stroke.

[41]  W. Feinberg,et al.  Fibrinolysis after acute ischemic stroke. , 1991, Thrombosis Research.

[42]  T. Omae,et al.  Activation of coagulation in acute cardioembolic stroke. , 1991, Stroke.